Clinical Trials Logo

Trismus clinical trials

View clinical trials related to Trismus.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06193720 Completed - Pain Clinical Trials

The Impact of Arnica Montana Following the Surgical Extraction of Impacted Third Molars

Start date: February 3, 2022
Phase: N/A
Study type: Interventional

Aim: The aim of this study is to evaluate the action of the homeopathic plant Arnica Montana on postoperative edema, pain and trismus after surgical extraction of impacted wisdom teeth. Materials and Methods: The study is a double-blinded clinical trial recruiting patients undergoing surgical extraction of symmetrically impacted maxillary or mandibular third molars (right and left side). Patients receive alternately and randomly the verum (Arnica Montana 12 CH) or the placebo, in the form of capsules, to be taken 1 day prior to surgery and for 7 days postoperatively. Clinical parameters are collected and include: pain score, maximum mouth opening and facial measurements to assess edema's intensity.

NCT ID: NCT05992233 Completed - Molar, Third Clinical Trials

"Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus"

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

Objective: To investigate the effects of single session dual wavelength low dose laser therapy to be applied after third molar tooth extraction on postoperative pain, edema and physical activities. Materials and Methods: Thirty-six patients who applied for the extraction of a Class III and position B lower impacted wisdom tooth were included in the study. The patients were divided into 2 groups as laser and control group. Envelope selection method was used for randomization of patients. After the surgery, a single session of double wavelength low-dose laser therapy was applied to the patients. On the 2nd and 7th postoperative days, pain was measured with the VAS scale, edema was measured by face measurements of 3 different points, and quality of life was measured with the modified Posse scale.

NCT ID: NCT05777668 Completed - Trismus Clinical Trials

A Predictive Nomogram for Trismus After Radiotherapy for Head and Neck Cancer

Start date: January 2017
Phase:
Study type: Observational

Background: The aim of this study is to develop a prediction model for radiation-induced trismus (maximal interincisal distance equal to or less than 35 mm) based on a multivariable analysis of dosimetric and clinical factors.

NCT ID: NCT05752305 Completed - Pain, Postoperative Clinical Trials

Use of Corticosteroids in Third Molar Surgery

Start date: January 15, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Surgical extraction of retained lower third molars is associated with the development of postoperative complications, including inflammation, trismus and postoperative pain, that lead to a decrease in patients' quality of life. Therefore, the use of drugs is essential to reduce the morbidity associated with surgery, with NSAIDs and corticosteroids being the most commonly used drugs.

NCT ID: NCT05679453 Completed - Pain, Acute Clinical Trials

Lornoxicam Versus Etodolac After Third Molar Surgery

Start date: July 20, 2022
Phase: Phase 4
Study type: Interventional

Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction

NCT ID: NCT05615181 Completed - Trismus Clinical Trials

Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)

TRISMUS
Start date: December 22, 2020
Phase:
Study type: Observational

A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).

NCT ID: NCT05466604 Completed - Pain Clinical Trials

Comparison of Hyaluronidase and Dexametasone in Reduction of Postoperative Edema

Start date: December 1, 2019
Phase: Phase 4
Study type: Interventional

The present study is designed to reveal effectiveness of hyaluronidase and dexamethasone on reduction of postoperative edema, pain, trismus, and infection. For this purpose, 60 participants with symmetrical mandibular wisdom teeth enrolled the present study. All measurements and evaluations were performed before and 1, 2, 3, and 7 days later the operation.

NCT ID: NCT05170516 Completed - Clinical trials for Impacted Third Molar Tooth

The Effect of Saline Irrigation at Different Temperatures on Pain, Edema, and Trismus After Impacted Third Molar Surgery

Start date: September 15, 2018
Phase: N/A
Study type: Interventional

Third molar surgery is one of the most common procedures in oral surgery and the most common postoperative complications are swelling, pain, and trismus. This study aims to evaluate the postoperative morbidity (pain, swelling, and trismus) in third molar surgery performed using different degrees of cooled and room temperature irrigation solutions.

NCT ID: NCT05126264 Completed - Pain Clinical Trials

Efficacy of Chronoterapy in Oral Surgery

ECOS
Start date: December 10, 2021
Phase: N/A
Study type: Interventional

Lower third molar extraction is one of the most common treatments in oral surgery practice. It is a treatment with inherent complications such as postoperative pain, swelling or trismus. In order to minimize disconfort after extraction, analgesic and anti-inflammatory medication is prescribed. Recently, it is seen that circadian rhythm may play an important role on drugs metabolism, modulating its effect depending on the moment of administration. The aim of the study is to analyze if dosage modification of a Non Steroideal Anti-Inflammatory (ibuprofen) affects on postoperative pain, swelling and open mouth limitation comparing to the normal dosage.

NCT ID: NCT04534426 Completed - Clinical trials for Impacted Third Molar Tooth

Topical Arnica and Mucopolysaccharide Polysulfate on Postoperative Pain, Edema and Trismus

Start date: December 1, 2018
Phase: Phase 4
Study type: Interventional

The present study was to evaluate the effect of topical Arnica and MPSP application with respect to visual analogue scale (VAS) scores, maximal interincisal opening (MIO) and edema values after mandibular impacted third molar removal on days 1, 3, 5 and 10 postoperatively. The following null hypotheses of the present research were determined as follows: usage of topical agents would not influence i) VAS scores, ii) MIO values, and iii) edema values on 1st, 3rd, 5th, and 10th days after the mandibular impacted third molar surgery